The effectiveness of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) on incident dementia in patients with diabetes and atrial fibrillation (AF) remains unknown. This study aimed to investigate the association between SGLT2i and… Click to show full abstract
The effectiveness of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) on incident dementia in patients with diabetes and atrial fibrillation (AF) remains unknown. This study aimed to investigate the association between SGLT2i and the risk of incident dementia in diabetic patients with AF, and to explore the interactions with oral anticoagulants or dipeptidyl peptidase‐4 inhibitors (DPP4i).
Keywords:
diabetic patients;
glucose transporter;
sodium glucose;
transporter inhibitors;
atrial fibrillation
Journal Title: Diabetes/Metabolism Research and Reviews
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes/Metabolism Research and Reviews
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!